Detection of Serun 90K/mac-2Bp in Non-Hodgkin's Lymphoma and Its Clinical Significance

ZHANG Dong-sheng,JIANG Wen-qi,LI Su,XIA Zhong-jun,Mao-Hua,CHEN Xiao-qin,Wang Feng-hua

DOI: https://doi.org/10.3969/j.issn.1007-3639.2006.02.015

2006-01-01

Abstract:Background and purpose:90K/Mac-2BP is a secreted glyloprotein.It's elevation in some cancer patients was reported to be associated with prognosis.In this study,we analyzed the potential significance of serum 90K/Mac-2BP as a tumor marker in NHLs.Methods:30 healthy donors and 160 NHL patients entered this study,including 30 remission patients、30 recurrent patients and 100 newly diagnosed patients before treatment.Serum 90K/Mac-2BP level was measured with the quantitative sandwich enzyme linked immunosorbent assay(ELISA),The difference of serum 90K/Mac-2BP in each terms and the relationship of serum 90K/Mac-2BP level clinicopathological features in newly diagnosed NHL patients before treatment was analyaed.Results:Serum 90k/Mac-2BP level of primary treatment group and relapsed group before treatment was higher than that of healthy donors and patients who were remission,the diffrence reached statistical significance(P0.05).The serum level between primary treatment group and recurrent group before treatment,and the level between patients who were in the status of remission and healthy donors was close to each other;the difference was not statistically significant(P0.05).The serum level of 90K/Mac-2BP of primary patients before treatment was not associated with age,gender,pathologic classification,performance status,Ann Arbor stage,international prognostic index(IPI),serum level of lactate dehydrogenase(LDH),bone marrow involvement,bulky disease(P0.05).Conclusions:The level of serum 90K/Mac-2BP was different in the groups of different disease periods in NHL;however,whether 90K could become a tumor marker of non-Hodgkin's lymphoma needs further research.